Gilead Sciences | Gilead Sciences | price-fixing or anti-competitive practices | 2024 | private lawsuit-federal | $246,750,000 |
Biogen Inc. | Biogen | benefit plan administrator violation | 2024 | private lawsuit-federal | $9,750,000 |
Hikma Pharmaceuticals | Hikma Pharmaceuticals | off-label or unapproved promotion of medical products | 2024 | MULTI-AG | $150,000,000 |
Johnson & Johnson | Johnson & Johnson | off-label or unapproved promotion of medical products | 2024 | WA-AG | $149,500,000 |
Indivior Inc. | Indivior PLC | price-fixing or anti-competitive practices | 2024 | private lawsuit-federal | $385,000,000 |
Teva | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2024 | MD-AG | $70,281,867 |
Allergan | AbbVie | off-label or unapproved promotion of medical products | 2024 | MD-AG | $38,166,450 |
MERCK SHARP & DOHME LLC | Merck | air pollution violation | 2024 | NJ-ENV | $33,200 |
Endo Health Solutions Inc. | Endo International | drug or medical equipment safety violation | 2024 | DOJ_CIVIL | $464,900,000 |
Amneal Pharmaceuticals | Amneal Pharmaceuticals | off-label or unapproved promotion of medical products | 2024 | MULTI-AG | $272,500,000 |
Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals | HHS civil monetary penalties | 2024 | HHSOIG | $170,000 |
Endo Health Solutions Inc. | Endo International | drug or medical equipment safety violation | 2024 | DOJ_CIVIL | $1,536,000,000 |
Gnc Holdings Llc | Harbin Pharmaceutical Group | benefit plan administrator violation | 2024 | EBSA | $10,001 |
Pfizer Inc. | Pfizer | price-fixing or anti-competitive practices | 2024 | private lawsuit-federal | $93,000,000 |
Bristol-Myers Squibb Company et al. | Bristol-Myers Squibb | product safety violation | 2024 | HI-AG | $458,006,000 |
Sanofi | Sanofi | product safety violation | 2024 | HI-AG | $458,006,000 |
Johnson & Johnson | Johnson & Johnson | consumer protection violation | 2024 | MULTI-AG | $700,000,000 |
Novel Laboratories Inc. | Lupin Limited | Controlled Substances Act violation | 2024 | DEA | $2,250,000 |
VERTEX PHARMACEUTICALS INCORPORATED | Vertex Pharmaceuticals | workplace safety or health violation | 2024 | OSHA | $9,000 |
PFIZER INC | Pfizer | workplace safety or health violation | 2024 | OSHA | $7,000 |
PHARMACIA & UPJOHN CO LLC | Pfizer | environmental violation | 2024 | EPA | $8,100 |
Pfizer Inc. | Pfizer | price-fixing or anti-competitive practices | 2024 | private lawsuit-federal | $50,000,000 |
Genentech Inc. | Roche | benefit plan administrator violation | 2024 | private lawsuit-federal | $250,000 |
Indivior | Indivior PLC | off-label or unapproved promotion of medical products | 2024 | MULTI-AG | $86,000,000 |
Wyeth Pharmaceuticals | Pfizer | price-fixing or anti-competitive practices | 2024 | private lawsuit-federal | $39,000,000 |
DePuy Synthes, Inc. | Johnson & Johnson | False Claims Act and related | 2023 | DOJ_CIVIL | $9,750,000 |
Ethicon | Johnson & Johnson | consumer protection violation | 2023 | KY-AG | $9,900,000 |
Sun Pharmaceuticals Industries Ltd | Sun Pharmaceuticals | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $17,357,000 |
Taro Pharmaceutical USA Inc. | Sun Pharmaceuticals | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $67,643,000 |
Johnson & Johnson | Johnson & Johnson | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $25,000,000 |
Forest Laboratories LLC | AbbVie | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $27,200,000 |
Johnson & Johnson | Johnson & Johnson | product safety violation | 2023 | private lawsuit-federal | $8,900,000,000 |
Johnson and Johnson | Johnson & Johnson | drug or medical equipment safety violation | 2023 | CA-AG | $302,000,000 |
Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2023 | CMS | $31,959 |
Takeda Pharmaceuticals | Takeda Pharmaceutical | benefit plan administrator violation | 2023 | private lawsuit-federal | $22,000,000 |
BRISTOL-MYERS SQUIBB | Bristol-Myers Squibb | environmental violation | 2023 | MA-ENV | $11,615 |
Indivior Inc. | Indivior PLC | price-fixing or anti-competitive practices | 2023 | MULTI-AG | $102,500,000 |
Teva Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | consumer protection violation | 2023 | KY-AG | $1,407,000 |
GlaxoSmithKline | GlaxoSmithKline | price-fixing or anti-competitive practices | 2023 | IN-AG | $1,270,000 |
Novartis AG | Novartis | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $126,850,000 |
Takeda Pharmaceuticals | Takeda Pharmaceutical | False Claims Act and related | 2023 | TX-AG | $21,350,000 |
Genentech | Roche | hazardous waste violation | 2023 | EPA | $158,208 |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2023 | DOJ_ANTITRUST | $275,000,000 |
Glenmark Pharmaceuticals Inc., USA | Glenmark Pharmaceuticals | price-fixing or anti-competitive practices | 2023 | DOJ_ANTITRUST | $30,000,000 |
ADVANCED STERILIZATION PRODUCTS INC | Johnson & Johnson | environmental violation | 2023 | NJ-ENV | $13,300 |
Pfizer Inc. | Pfizer | employment discrimination | 2023 | OFCCP | $2,500,000 |
Novartis Pharmaceuticals Corporation | Novartis | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $30,000,000 |
Teva Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2023 | KY-AG | $71,477,474 |
Allergan PLC | AbbVie | off-label or unapproved promotion of medical products | 2023 | KY-AG | $48,666,145 |
Merck | Merck | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $56,000,000 |
Glenmark Pharmaceuticals | Glenmark Pharmaceuticals | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $14,000,000 |
Indivior Inc. | Indivior PLC | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $30,000,000 |
AKORN OPERATING COMPANY LLC | Akorn Inc. | wage and hour violation | 2023 | IL-DOL | $13,000 |
AKORN OPERATING COMPANY LLC | Akorn Inc. | wage and hour violation | 2023 | IL-DOL | $10,600 |
Akorn Inc | Akorn Inc. | wage and hour violation | 2023 | IL-DOL | $15,000 |
Ultragenyx Pharmaceutical Inc. | Ultragenyx Pharmaceutical | False Claims Act and related | 2023 | DOJ_CIVIL | $6,000,000 |
ULTRAGENYX PHARMACEUTICAL | Ultragenyx Pharmaceutical | workplace safety or health violation | 2023 | OSHA | $12,054 |
GNC HOLDINGS INC. | Harbin Pharmaceutical Group | workplace safety or health violation | 2023 | OSHA | $17,858 |
IDEXX DISTRIBUTION, INC. | IDEXX Laboratories | workplace safety or health violation | 2023 | OSHA | $32,245 |
VERSUM MATERIALS | Merck KGaA (EMD) | workplace safety or health violation | 2023 | OSHA | $8,438 |
PERRIGO COMPANY PLC | Perrigo | workplace safety or health violation | 2023 | OSHA | $12,600 |
BRISTOL-MYERS SQUIBB COMPANY | Bristol-Myers Squibb | workplace safety or health violation | 2023 | OSHA | $80,655 |
MERCK SHARP & DOHME CORP. | Merck | environmental violation | 2023 | EPA | $6,250 |
Genentech | Roche | environmental violation | 2023 | EPA | $158,209 |
Endo Health Solutions Inc. and Endo Pharmaceuticals Inc. | Endo International | off-label or unapproved promotion of medical products | 2022 | FL-AG | $65,000,000 |
Teva Pharmaceutical Industries Ltd. | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | TX-AG | $225,000,000 |
Mallinckrodt ARD LLC | Mallinckrodt | False Claims Act and related | 2022 | DOJ_CIVIL | $260,000,000 |
Perrigo Co. | Perrigo | consumer protection violation | 2022 | CA-MULTI | $360,000 |
Pfizer | Pfizer | consumer protection violation | 2022 | CO-AG | $137,174 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | FL-AG | $278,826,499 |
Allergan Ltd. et al. | AbbVie | off-label or unapproved promotion of medical products | 2022 | FL-AG | $134,200,000 |
Endo Health Solutions and Endo Pharmaceuticals | Endo International | off-label or unapproved promotion of medical products | 2022 | FL-AG | $65,000,000 |
Pfizer Inc. | Pfizer | consumer protection violation | 2022 | KS-AG | $85,564 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | RI-AG | $21,000,000 |
Allergan Ltd. | AbbVie | off-label or unapproved promotion of medical products | 2022 | RI-AG | $7,500,000 |
Dr. Reddy's Laboratories | Dr. Reddy's Laboratories | False Claims Act and related | 2022 | TX-AG | $12,900,000 |
Pfizer | Pfizer | consumer protection violation | 2022 | VT-AG | $34,564 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | WV-AG | $83,000,000 |
Allergan | AbbVie | off-label or unapproved promotion of medical products | 2022 | WV-AG | $78,000,000 |
Janssen Pharmaceuticals | Johnson & Johnson | off-label or unapproved promotion of medical products | 2022 | WV-AG | $99,000,000 |
Endo Pharmaceuticals | Endo International | off-label or unapproved promotion of medical products | 2022 | CA-SFCA | $10,000,000 |
Astellas Pharma US, Inc. | Astellas Pharma | campaign finance violation | 2022 | FEC | $7,500 |
Pfizer | Pfizer | consumer protection violation | 2022 | AZ-AG | $124,527 |
Akorn Operating Company LLC | Akorn Inc. | False Claims Act and related | 2022 | DOJ_CIVIL | $7,900,000 |
Pfizer, Inc. | Pfizer | consumer protection violation | 2022 | KS-AG | $85,000 |
Endo International plc | Endo International | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $450,000,000 |
Allergan | AbbVie | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $2,370,000,000 |
Teva Pharmaceuticals | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $4,250,000,000 |
Janssen Pharmaceuticals/Johnson & Johnson | Johnson & Johnson | off-label or unapproved promotion of medical products | 2022 | NH-AG | $40,500,000 |
Allergan | AbbVie | off-label or unapproved promotion of medical products | 2022 | CA-SFCA | $27,000,000 |
Teva Parmaceuticals | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | CA-SFCA | $27,000,000 |
Novo Nordisk Inc | Novo Holdings A/S | False Claims Act and related | 2022 | USAO | $6,300,000 |
Janssen Pharmaceuticals, Inc. | Johnson & Johnson | product safety violation | 2022 | private lawsuit-federal | $150,000,000 |
Biogen Inc. | Biogen | False Claims Act and related | 2022 | DOJ_CIVIL | $900,000,000 |
Johnson & Johnson | Johnson & Johnson | off-label or unapproved promotion of medical products | 2022 | NH-AG | $40,500,000 |
Teva Pharmaceuticals, Ltd. | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | NY-AG | $313,343,793 |
CSL Plasma Inc. | CSL Limited | privacy violation | 2022 | private lawsuit-federal | $9,900,000 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $8,200,000 |
Allergan | AbbVie | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $4,800,000 |
Actavis Elizabeth LLC | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $1,100,000 |
Allergan Inc. | AbbVie | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $30,000,000 |